Replimune (REPL) stock in focus as the FDA rejects its lead drug RP1 as part of a combination regimen for melanoma, a type of ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...

These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.

The Baloch Liberation Army has claimed responsibility for a bomb blast in Quetta that killed Major Anwar Kakar, a senior ...

FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial ...

Malvern, Pennsylvania Tuesday, July 22, 2025, 17:00 Hrs [IST] ...

Denali's lead drug for Hunter syndrome wins FDA Priority Review, marking a key step toward commercial-stage status.

Amid the dusty plateaus and strategic choke points of Balochistan, a covert conflict is rapidly intensifying — one that ...

The Baloch Army (BLA) has claimed responsibility for an attack on a bus carrying Pakistan Army personnel in the Quetta and ...

The Baloch Army (BLA) has claimed responsibility for an attack on a bus carrying Pakistan Army personnel in the Quetta and ...

Fateh Squad of Baloch Liberation Army ambushed a military bus going from Karachi to Quetta killing at least 29 military ...